| 000 | 01520 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513195315.0 | ||
| 264 | 0 | _c19991202 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a1524-9557 | ||
| 024 | 7 |
_a10.1097/00002371-199911000-00007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrup, O C | |
| 245 | 0 | 0 |
_aCytokine depot formulations as adjuvants for tumor vaccines. I. Liposome-encapsulated IL-2 as a depot formulation. _h[electronic resource] |
| 260 |
_bJournal of immunotherapy (Hagerstown, Md. : 1997) _cNov 1999 |
||
| 300 |
_a525-38 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _ximmunology |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aImmunotherapy, Active |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _ximmunology |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 |
_aMelanoma, Experimental _xprevention & control |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aKroll, I | |
| 700 | 1 | _aBöse, G | |
| 700 | 1 | _aFalkenberg, F W | |
| 773 | 0 |
_tJournal of immunotherapy (Hagerstown, Md. : 1997) _gvol. 22 _gno. 6 _gp. 525-38 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002371-199911000-00007 _zAvailable from publisher's website |
| 999 |
_c10527013 _d10527013 |
||